Meng (Mena) Ru

Meng (Mena) Ru

PhD student in Cancer Epidemiology

Johns Hopkins University

Biography

I am a 1st-year PhD student of cancer epidemiology in the Department of Epidemiology at Johns Hopkins University Bloomberg School of Public Health.

Prior to joining Hopkins, I was a biostatistician at Mount Sinai Hospital, NY for 4 years, where I provided statistical consultation and performed data analysis for clinical cancer studies, mostly on breast cancer, prostate cancer and radiation oncology. I also helped the clinical investigators develop early-phase clinical trial protocols to ensure adequate study design and sufficient statistical power.

For my PhD study, I’m interested in utilizing novel statistical genetic methods to find the association of genetic markers in the multi-omics data and cancer outcomes.

Interests

  • Genetic Epidemiology
  • Statistical Genetics

Education

  • PhD student in Epidemiology (Cancer Epidemiology Track), 2024 (Expected)

    Johns Hopkins Bloomberg School of Public Health

  • MS in Biostatistics, 2016

    Columbia University

  • BSc in Pharmacy, 2014

    China Pharmaceutical University

Experience

 
 
 
 
 

Biostatistician II

Mount Sinai Hospital

Jun 2016 – May 2020 New York, NY

Responsibilities include:

  • Provided statistical consultation and support for breast cancer, radiation oncology comparative-effectiveness studies to develop adequate study design and analysis plans, with experience working with large administrative databases such as SEER and NCDB.
  • Independently performed data analysis using SAS and R and prepared graphs and tables of research findings on 20+ peer-reviewed publications.
 
 
 
 
 

Research Assistant

The Brooklyn Hospital Center

Jul 2015 – May 2016 Brooklyn, NY

Served as data analyst on a study to determine factors affecting asthma-related hospitalizations and emergency department visits among adults at a New York inner-city hospital. Responsibilites include:

  • Proposed survival analytic model strategies for epidemiologic analysis of a retrospective cohort study based on secondary data.
  • Data manipulation by identifying claim data (i.e. ICD-9 code and CPT code) to restrict the cohort based on inclusion and exclusion criteria to meet analysis requirements.
 
 
 
 
 

Primary Market Research Intern

QuintileIMS (formerly IMS Health)

Jun 2014 – Aug 2016 Beijing, China
Participated in five market research projects about the evaluation of market performance of prescription drugs for clients including Pfizer, Bayer, etc.

Skills

Statistics

100%

R

80%

Piano

50%

Photography

20%

Languages

Mandarin, French, Japanese

Recent Publications

Quickly discover relevant content by filtering publications.

Safety of nivolumab in combination with prior or concurrent radiation therapy in hepatocellular carcinoma

BRCA Mutation Association with Recurrence Score and Discordance in a Large Oncotype Database

Diabetes and Metformin Association with Recurrence Score in a Large Oncotype Database of Breast Cancer Patients

Use of neoadjuvant versus adjuvant chemotherapy for hormone receptor-positive breast cancer: a National Cancer Database (NCDB) study

Utilization Patterns of Single Fraction Radiation Therapy for Multiple Myeloma

Recent Posts

Contact